Literature DB >> 7713498

Molecular cloning, cDNA sequence, and chromosomal localization of the human phosphatidylinositol 3-kinase p110 alpha (PIK3CA) gene.

S Volinia1, I Hiles, E Ormondroyd, D Nizetic, R Antonacci, M Rocchi, M D Waterfield.   

Abstract

Phosphatidylinositol (PI) 3-kinase is a heterodimeric enzyme comprising a 110-kDa catalytic subunit and an 85-kDa regulatory subunit that binds to tyrosine phosphopeptide sites linked directly or indirectly to receptors serving diverse signal functions. Knowledge of the structure and function of PI 3-kinase was greatly advanced by the purification, cDNA cloning, and subsequent expression of the bovine enzyme. Here the cloning of the cDNA for the human p110 alpha subunit of PI 3-kinase (PIK3CA), encoding a protein 99% identical to the bovine p110, and of its gene in YAC is described. The chromosomal localization of the gene for PIK3CA is shown to be at 3q21-qter as determined using somatic cell hybrids. In situ hybridization performed using Alu-PCR from the YAC DNA located the gene in 3q26.3.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7713498     DOI: 10.1006/geno.1994.1655

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  31 in total

1.  RNAi knockdown of PIK3CA preferentially inhibits invasion of mutant PIK3CA cells.

Authors:  Xin-Ke Zhou; Sheng-Song Tang; Gao Yi; Min Hou; Jin-Hui Chen; Bo Yang; Ji-Fang Liu; Zhi-Min He
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

2.  Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction.

Authors:  M P Wymann; G Bulgarelli-Leva; M J Zvelebil; L Pirola; B Vanhaesebroeck; M D Waterfield; G Panayotou
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  PIK3CA mutation in Chinese patients with lung squamous cell carcinoma.

Authors:  Jinglin Yu; Hua Bai; Zhijie Wang; Zhigang Wei; Xiaosheng Ding; Jianchun Duan; Lu Yang; Meina Wu; Yuyan Wang; Jie Wang
Journal:  Chin J Cancer Res       Date:  2013-08       Impact factor: 5.087

4.  PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells.

Authors:  Michaela J Higgins; Julia A Beaver; Hong Yuen Wong; John P Gustin; Josh D Lauring; Joseph P Garay; Hiroyuki Konishi; Morassa Mohseni; Grace M Wang; Justin Cidado; Danijela Jelovac; David P Cosgrove; Akina Tamaki; Abde M Abukhdeir; Ben Ho Park
Journal:  Cancer Biol Ther       Date:  2011-02-01       Impact factor: 4.742

5.  Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma.

Authors:  Karl C Bruckman; Frank Schönleben; Wanglong Qiu; Victoria L Woo; Gloria H Su
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-09-01

6.  RAS Interaction with PI3K: More Than Just Another Effector Pathway.

Authors:  Esther Castellano; Julian Downward
Journal:  Genes Cancer       Date:  2011-03

7.  The structure and function of p55PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase.

Authors:  S Pons; T Asano; E Glasheen; M Miralpeix; Y Zhang; T L Fisher; M G Myers; X J Sun; M F White
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

Review 8.  Actin cytoskeletal mediators of motility and invasion amplified and overexpressed in head and neck cancer.

Authors:  Laura C Kelley; Sohrab Shahab; Scott A Weed
Journal:  Clin Exp Metastasis       Date:  2008-03-07       Impact factor: 5.150

9.  Experimental verification of a predicted novel microRNA located in human PIK3CA gene with a potential oncogenic function in colorectal cancer.

Authors:  Ali Jason Saleh; Bahram M Soltani; Sadat Dokanehiifard; Abdallah Medlej; Mahmoud Tavalaei; Seyed Javad Mowla
Journal:  Tumour Biol       Date:  2016-08-10

10.  Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer.

Authors:  L Quaye; H Song; S J Ramus; A Gentry-Maharaj; E Høgdall; R A DiCioccio; V McGuire; A H Wu; D J Van Den Berg; M C Pike; E Wozniak; J A Doherty; M A Rossing; R B Ness; K B Moysich; C Høgdall; J Blaakaer; D F Easton; B A J Ponder; I J Jacobs; U Menon; A S Whittemore; S Krüger-Kjaer; C L Pearce; P D P Pharoah; S A Gayther
Journal:  Br J Cancer       Date:  2009-02-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.